Human Vaccines Market to Advance at CAGR of 8.7% During 2019–2027, Says TMR

Transparency Market Research

Transparency Market Research

ALBANY, NY, April 15, 2022 (GLOBE NEWSWIRE) — Extremely low risk of persistent adverse side effects of approved or authorized vaccines is a key aspect propelling the expansion of avenues in the human vaccines market. Success rates of human vaccines are underpinned by the fact a number of diseases have been prevented or eradicated since history with national immunization programs. The global valuation of the human vaccines market is projected to advance at CAGR of 8.7% during 2019–2027.

Rise in number of national immunization programs in developed countries is a key driver for revenue sales in the human vaccines market. Of note, routine immunization programs in children have helped prevent polio (OPV), measles, mumps, rubella, typhoid, varicella, rotavirus, and influenza.

Request Brochure of Human Vaccines Market Research Report –

Expanding understanding of infectious disease epidemiology has helped companies develop human vaccines that have played a crucial role in reducing the global burden of infectious diseases. The high mortality and morbidity of infectious diseases in non-industrialized world as well industrialized nations is a key driver of extensive R&D in the human vaccines market. For instance, nationwide immunization programs with pneumococcal conjugate vaccine (PCV7) in children have been helpful in reducing the incidence of invasive pneumococcal disease.

Key Findings of Human Vaccines Market Study

  • Intensive R&D on Human Immune Response to Immunization Help Reduce Prevalence of Infectious Diseases: The high prevalence of infectious diseases notably in developed nations has caused glaring morbidity and mortality. This has spurred the need for vaccines, thus invigorating development of products in the human vaccines market. The indisputable role of human vaccines in reducing the burden of large pandemics has nudged vaccine developer pour in billions of dollars over the past few decades. In recent times, extensive clinical trials on COVID-19 vaccines in several countries are bolstering the revenue possibilities in the human vaccines market.

  • New Approaches in Testing and Development to Boost Protective and Durable Response: Growing understanding of human immune response to immunization has accelerated the development of more efficacious products in the human vaccines market. Furthermore, strides made in computational and systems biology, along with rapidly expanding scope of bioinformatics and machine learning in vaccine clinical trials, are enriching the landscape of the human vaccines market.

New approaches including system immunology are crucial for improving the success rates. Novel approaches help in augmenting protective and durable response, wherein the impact of psychosocial and cultural factors along with the overall biology plays vital role. Some of the key product types propelling sales in human vaccines market are conjugate, recombinant, inactivated, combination, and attenuated vaccines.

Request for Analysis of COVID-19 Impact on Human Vaccines Market –

Human Vaccines Market: Key Drivers

  • Vaccines have shown demonstrable benefits due to protective and/or durable response for many infectious pathogens, thus boosting the success of various vaccination programs globally over the decades. This has expanded the avenue in the human vaccines market.

  • Growing government spending on improving public health infrastructure, coupled with rising awareness about immunization programs, has been propelling the prospects of the human vaccines market.

Get Exclusive PDF Sample Copy of Human Vaccines Market Report

Human Vaccines Market: Key Players

The marketing strategies by a number of international and regional players continue to shape the competition landscape, find the TMR study on the human vaccines market. Some of the prominent players are Shenzhen Kangtai Biological Products Co., Ltd., Sanofi SA, Pfizer, Inc., Novartis AG, Mymetics, Merck & Co, Inc., Johnson & Johnson, GlaxoSmithKline plc., and AstraZeneca plc.

Make an Inquiry Before Buying –
The global human vaccines market is divided into:

  • Global Human Vaccines Market, by Vaccine Type

    • conjugate

    • Recombinant

    • inactivated

    • Combination

    • attenuated

    • Others

  • Global Human Vaccines Market, by Product Type

    • pneumococcal

    • Influenza

    • Hepatitis

    • HPV

    • Meningococcal

    • rotavirus

    • Measles and Rubella

    • typhoid

    • Combination

    • Others

  • Global Human Vaccines Market, by Distribution Channel

    • Hospital Pharmacies

    • drugstores

    • Others

  • Global Human Vaccines Market, by Age Group

    • Pediatrics

    • teenagers

    • adults

    • Geriatrics

  • Global Human Vaccines Market, by Region

    • North America

    • Europe

    • Asian-Pacific

    • Latin America

    • Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Meningitis Vaccine Market: Meningitis is an inflammation (swelling) of the defensive layers called meninges covering the brain and spinal cord. A bacterial or viral contamination of the fluid encompassing the brain and spinal cord ordinarily causes the swelling. However, wounds, disease, certain medications, and different kinds of infections can also cause meningitis.

Swine Flu Vaccine Market: Swine flu is infection of the respiratory system caused by influenza viruses. These viruses also infect the respiratory system of pigs causing barking cough, decrease in appetite, nasal secretions, and listless behavior. Influenza viruses can also be transmitted to humans. Swine flu viruses can induce genetic changes or mutations so that these are easily transmissible among humans.

Pentavalent Vaccine Market: Vaccines are biological preparations that provide immunity against a specific or number of diseases. Pentavalent vaccine is a combination of five vaccines. It provides immunity to children against five potentially fatal diseases: diphtheria, pertussis, tetanus, hepatitis B, and hemophilius influenza type b. Governments of several countries such as India have decided to include the vaccine in the national immunization schedule.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update –


Rohit Bhissey

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY-12207
United States
USA – Canada Toll Free: 866-552-3453
Follow Us: Twitter | LinkedIn
Browse PR –

Leave a Reply

Your email address will not be published. Required fields are marked *